Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regionalization of Testis Cancer Care-Is It Necessary?
Heidenreich A, Paffenholz P, Pfister D. Heidenreich A, et al. Urol Clin North Am. 2024 Aug;51(3):421-427. doi: 10.1016/j.ucl.2024.03.010. Epub 2024 Apr 9. Urol Clin North Am. 2024. PMID: 38925744 Review.
Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissue.
Nestler T, Kremer L, von Brandenstein M, Wittersheim M, Paffenholz P, Wagener-Ryczek S, Quaas A, Hellmich M, Müller S, Pfister D, Odenthal M, Heidenreich A. Nestler T, et al. Among authors: heidenreich a. Cancer. 2023 Feb 15;129(4):634-642. doi: 10.1002/cncr.34571. Epub 2022 Dec 11. Cancer. 2023. PMID: 36504384 Free article.
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.
Antonelli L, Ardizzone D, Ravi P, Bagrodia A, Mego M, Daneshmand S, Nicolai N, Nazzani S, Giannatempo P, Franza A, Heidenreich A, Paffenholz P, Saoud R, Eggener S, Ho M, Oswald N, Olson K, Tryakin A, Fedyanin M, Naoun N, Javaud C, Fizazi K, King JM, Adra N, Douglawi A, Cary C, Sweeney C, Fankhauser CD. Antonelli L, et al. Among authors: heidenreich a. Eur J Cancer. 2023 Mar;182:144-154. doi: 10.1016/j.ejca.2022.12.032. Epub 2023 Jan 20. Eur J Cancer. 2023. PMID: 36787661 Free article.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
Fizazi K, Piulats JM, Reaume MN, Ostler P, McDermott R, Gingerich JR, Pintus E, Sridhar SS, Bambury RM, Emmenegger U, Lindberg H, Morris D, Nolè F, Staffurth J, Redfern C, Sáez MI, Abida W, Daugaard G, Heidenreich A, Krieger L, Sautois B, Loehr A, Despain D, Heyes CA, Watkins SP, Chowdhury S, Ryan CJ, Bryce AH; TRITON3 Investigators. Fizazi K, et al. Among authors: heidenreich a. N Engl J Med. 2023 Feb 23;388(8):719-732. doi: 10.1056/NEJMoa2214676. Epub 2023 Feb 16. N Engl J Med. 2023. PMID: 36795891 Free PMC article. Clinical Trial.
Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer.
Rosenbrock J, Baues C, Kreis M, Fouassi R, Celik E, Paffenholz P, Pfister D, Heidenreich A, Marnitz S. Rosenbrock J, et al. Among authors: heidenreich a. Strahlenther Onkol. 2023 Jun;199(6):574-584. doi: 10.1007/s00066-023-02060-2. Epub 2023 Mar 17. Strahlenther Onkol. 2023. PMID: 36930248 Free PMC article.
German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measures.
Schoch J, Haunschild K, Strauch A, Nestler K, Schmelz H, Paffenholz P, Pfister D, Persigehl T, Heidenreich A, Nestler T. Schoch J, et al. Among authors: heidenreich a. World J Urol. 2023 May;41(5):1353-1358. doi: 10.1007/s00345-023-04364-5. Epub 2023 Apr 4. World J Urol. 2023. PMID: 37014392 Free PMC article.
793 results